Active substance
Results for the substance risdiplam
2 results
About this active substance
Risdiplam is a medication used for the treatment of spinal muscular atrophy (SMA) in patients aged 2 months and older. It works by increasing the production of functional SMN protein, which is essential for the health of motor neurons.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as fever, diarrhea, or upper respiratory tract infections. It is important to inform the doctor of any unusual symptoms.
Common side effects include fever, diarrhea, and upper respiratory tract infections. In rare cases, severe reactions such as liver failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as fever, diarrhea, or upper respiratory tract infections. It is important to inform the doctor of any unusual symptoms.
Common side effects include fever, diarrhea, and upper respiratory tract infections. In rare cases, severe reactions such as liver failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.